DelMar Pharmaceuticals’ Lung Cancer Drug VAL-083 Gets Notice of Allowance For Second U.S. Patent
Lung cancer News, News
DelMar Pharmaceuticals, a biotechnology company developing proven cancer therapies in new orphan drug indications, has announced that the United States Patent and Trademark Office (USPTO) issued a notice of allowance ... Read more